These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22659519)

  • 1. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.
    Anstee QM; Day CP
    J Hepatol; 2012 Nov; 57(5):1097-109. PubMed ID: 22659519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [S-adenosyl-L-methionine (SAMe) and its use in hepatology].
    Frezza M; Terpin MM; Peri A
    Minerva Gastroenterol Dietol; 1992; 38(3):145-51. PubMed ID: 1299337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D
    Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 5. S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
    Guo T; Chang L; Xiao Y; Liu Q
    PLoS One; 2015; 10(3):e0122124. PubMed ID: 25774783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.
    Bottiglieri T
    Am J Clin Nutr; 2002 Nov; 76(5):1151S-7S. PubMed ID: 12418493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.
    Friedel HA; Goa KL; Benfield P
    Drugs; 1989 Sep; 38(3):389-416. PubMed ID: 2680435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ademetionine: the state of the art and future prospects].
    Almasio P; Pagliaro L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():52S-55S. PubMed ID: 8117523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosyl-L-methionine: its role in the treatment of liver disorders.
    Lieber CS
    Am J Clin Nutr; 2002 Nov; 76(5):1183S-7S. PubMed ID: 12418503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of S-adenosyl-L-methionine in liver health and injury.
    Mato JM; Lu SC
    Hepatology; 2007 May; 45(5):1306-12. PubMed ID: 17464973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].
    De Caprio M; Carbone G; Cerotto GM; Corbosiero L; Vitale A
    Clin Ter; 1980 Mar; 92(6):587-602. PubMed ID: 7460488
    [No Abstract]   [Full Text] [Related]  

  • 12. [S-adenosyl L-methionine in CNS diseases].
    Krzystanek M; Pałasz A; Krzystanek E; Krupka-Matuszczyk I; Wiaderkiewicz R; Skowronek R
    Psychiatr Pol; 2011; 45(6):923-31. PubMed ID: 22335134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is SAMe? S-Adenosylmethionine.
    Cowley G; Underwood A
    Newsweek; 1999 Jul; 134(1):46-50. PubMed ID: 10538206
    [No Abstract]   [Full Text] [Related]  

  • 14. [S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].
    Frezza M; Pozzato G; Valente G; Gilotta S; Milani S; Nicolini R
    Minerva Med; 1977 Apr; 68(17):1105-14. PubMed ID: 857203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?
    Osman E; Owen JS; Burroughs AK
    Aliment Pharmacol Ther; 1993 Feb; 7(1):21-8. PubMed ID: 8439634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies].
    Cantoni L; Maggi G; Mononi G; Preti G
    Minerva Med; 1975 May; 66(33):1581-9. PubMed ID: 1095963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Various effects of SAM dependent transmethylations in hepatology].
    Labò G; Gasbarrini G; Miglio F
    Minerva Med; 1972 May; 63(35):2007-17. PubMed ID: 5029206
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of SAMe in the treatment of liver disease.
    Williams R; Lieber CS
    Drugs; 1990; 40 Suppl 3():1-2. PubMed ID: 2081475
    [No Abstract]   [Full Text] [Related]  

  • 19. Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view.
    Testino G; Leone S; Ansaldi F; Borro P
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):341-56. PubMed ID: 24212353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-adenosylmethionine metabolism and liver disease.
    Mato JM; Martínez-Chantar ML; Lu SC
    Ann Hepatol; 2013; 12(2):183-9. PubMed ID: 23396728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.